Inventors list |
Agents list |
Assignees list |
List by place |
Classification tree browser |
Top 100 Inventors |
Top 100 Agents |
Top 100 Assignees |
Last week patent highlights (10-29-09):
1. P13 Kinase Antagonists - novel PI3-Kinase antagonists and methods of use thereof
2. PURINE DERIVATIVES - compounds of formula 1 STR00001 or pharmaceutically acceptable salts thereof, whereinone of R
3. CYCLOPROPANECARBOXYLATE ESTERS OF ACYCLOVIR
4. ANTIVIRAL FORMULATION - topical antiviral composition comprising acyclovir penciclovir and/or omaciclovir in a glucocorticoid-free pharmaceutical
5. Pyridopyrimidinone Inhibitors of Pl3Kalpha
6. Cyclopentenol Nucleoside Compounds Intermediates for their Synthesis and Methods of Treating Viral Infections
7. 7-[2-[4-(6-FLUORO-3-METHYL-1,2-BENZISOXAZOL-5-YL)-1-PIPERAZINYL]ETHYL]-2-(- 1-PROPYNYL)-7H-PYRAZOLO-[4,3-e]-[1,2,4]-TRIAZOLO-[1,5-c]-PYRIMIDIN-5-AMINE
8. 2,3-DIHYDRO-IMINOISOINDOLE DERIVATIVES - compound represented by the following general formula or a salt thereof has serine protease inhibiting activity
9. AZACYCLOALKANE DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE
10. Spiroketone Acetyl-CoA Carboxylase Inhibitors
11. SPIROCHROMANON DERIVATIVES - compound of a general formula : wherein Ar1 represents a group formed from an aromatic ring selected from a group
12. Use of Buprenorphine or N-Alkylated Derivatives Thereof for Wound Healing
13. Novel compositions and formulations - There is provided according to the invention a non-pressurised pharmaceutical liquid solution spray composition
14. Prophylactic/therapeutic agent for alzheimer's disease
15. BIOAVAILABILITY OF ACTIVE SUBSTANCES HAVING AN AMIDINE FUNCTION IN MEDICAMENTS
16. MACROLIDES - stabilization of poly-ene macrolides and to a particular macrolide obtained in crystalline form
17. POLYMORPHS OF HYDROCHLORIDE SALT OF 5-(3-(ETHYLSULFONYL)PHENYL)-3,8-DIMETHYL-N-(1-METHYLPIPERIDIN-4-YL)-9H-PY- RIDO[2,3-B]INDOLE-7-CARBOXAMIDE AND METHODS OF USE THEREFOR
18. 1-AMINO IMIDAZO-CONTAINING COMPOUNDS AND METHODS
19. 1,7-Naphthyridines - There are provided according to the invention novel compounds of formula and pharmaceutically acceptable salts and solvates thereof
20. Thiazole compounds and methods of use - methods of using thiazole compounds of Formula I and Formula II and compositions thereof for treating diseases
21. DIAMINE DERIVATIVES - diamine compounds which inhibit activated blood coagulation factor X and exhibit an anticoagulant effect and there uses for
22. 2-Aryl-and 2-Heteroarylthiazolyl Compounds, Methods for Their Preparation and Use Thereof
23. PHARMACEUTICAL FORMULATIONS COMPRISING CLOPIDOGREL
24. AMINOPHENYL DERIVATIVES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS
25. CHEMICAL COMPOUNDS - of formula : STR00001 or pharmaceutically acceptable salts thereof which possess CSF-1R kinase inhibitory activity and are
26. Piperdine Glycine Transporter Inhibitors
27. USE OF SOLUBLE EPOXIDE HYDROLASE INHIBITORS IN THE TREATMENT OF SMOOTH MUSCLE DISORDERS
28. ANTI-MANIC EFFECTIVE DOSES OF SERTINDOLE
29. Sulfonamide containing compounds for treatment of inflammatory disorders
30. Therapeutic agent for intestinal diseases and visceral pain
31. Novel chemical compounds - This invention relates to newly identified compounds for inhibiting hYAK3 and/or CK2 proteins and methods for treating
32. 6,11-BICYCLOLIDES: BRIDGED BIARYL MACROLIDE DERIVATIVES
33. METHOD OF TREATING OF DEMYELINATING DISEASES OR CONDITIONS
34. Flea control agent containing N-Substituted indole derivative
35. FXR AGONISTS - Compounds of formula wherein variables are as defined herein and their pharmaceutical compositions and methods of use are disclosed as
36. Fungicide n-cycloalkyl-carboxamide, thiocarboxamide and n-substituted-carboximidamide derivatives
37. 2-SULFANYL-SUBSTITUTED IMIDAZOLE DERIVATIVES AND THEIR USE AS CYTOKINE INHIBITORS
38. AMIDO DERIVATIVES-CONTAINED PHARMACEUTICAL COMPOSITION
39. Benzimidazole derivative and use as a II receptor antagonist
40. USE OF EPOTHILONE D IN TREATING TAU-ASSOCIATED DISEASES INCLUDING ALZHEIMER'S DISEASE
41. Epothilones C, D, E, and F, Preparation and Compositions
42. Aminocyclohexanes as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
43. Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
44. SUBSTITUTED OXAZOLIDINONES - new oxazolidinone modulators of skeletal muscle function and tone
45. Compounds I - Compounds of formula I STR00001 wherein R1 Z
46. METHOD FOR INHIBITING MYCOTOXIN PRODUCTION
47. METHOD TO USE OXYMETAZOLINE TO INTERRUPT THE DEVELOPMENT OF THE COMMON COLD SYNDROME
48. DUAL-ACTING ANTIHYPERTENSIVE AGENTS - compounds having the formula: STR00001 wherein: Q W Y
49. Therapeutic Agent for Keratoconjunctival Disorder
50. INHIBITION OF BACTERIAL BIOFILMS WITH IMIDAZOLE-PHENYL DERIVATIVES
51. PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF NEPHRITIS AND MANUFACTURING METHOD THEREOF
52. POLYMORPHS OF A HYDROISOINDOLINE TACHYKININ RECEPTOR ANTAGONIST
53. ION CHANNEL MODULATING ACTIVITY II - Methods, compositions, dosing regimes, and routes of administration for the treatment or prevention of arrhythmias
54. Genetic and Epigenetic Alterations In the Diagnosis and Treatment of Cancer
55. Markers and Methods for Assessing and Treating Psoriasis and Related Disorders
56. MODIFIED siRNA MOLECULES AND USES THEREOF
57. ANALYSIS OF METHYLATED NUCLEIC ACID - method for analysis methylation patterns in DNA and identifying aberrantly methylated genes in disease tissue
58. Pancreatic Cancer Genes - the art with the DNA coding sequences of polynucleotides that are up-or-down-regulated in cancer and dysplasia
59. WWOX Vectors and Uses in Treatment of Cancer
60. Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
61. HUMAN RNASE III AND COMPOSITIONS AND USES THEREOF
62. Compositions and methods for inhibiting the synthesis or expression of MMP-1
63. Process for the Selection of HIV-1 Subtype C Isolates, Selected HIV-1 Subtype Isolates, Their Genes and Modifications and Derivatives Thereof
64. LONG-ACTING POLYPEPTIDES AND METHODS OF PRODUCING SAME
65. METHODS INVOLVING ALDOSE REDUCTASE INHIBITION
66. MODULATION OF TUDOR-SN EXPRESSION - Compounds, compositions and methods are provided for modulating the expression of Tudor-SN
67. BRYOSTATIN ANALOGUES, SYNTHETIC METHODS AND USES
68. CYCLIC 1-(ACYLOXY)-ALKYL PRODRUGS OF GABA ANALOGS, COMPOSITIONS AND USES THEREOF
69. Salts of Dihydroxyanthraquinone Carboxylic Acids and Their Therapeutic Use
70. Inhibitors of Phosphodiesterase Types 1 To 5 Based on Dioclein, Floranol, and Analogs Thereof
71. ANTIFUNGAL COMPOUNDS - having a benzofuran structure
72. Treatment of Non-Localized Inflammation with pan-HDAC Inhibitors
73. Lipoxin Compounds and Their use in Treating Cell Proliferative Disorders
74. Process for Synthesizing Atazanavir - This invention relates to a process for synthesizing Atazanvir including novel intermediates and novel steps to
75. 4-TRIMETHYLAMMONIO-BUTYRATES AS CPT2 INHIBITORS
76. COMPOSITION AND METHOD FOR INCREASING THE ANABOLIC STATE OF MUSCLE CELLS
77. Method for Lowering Risk of Cardiovascular Diseases
78. NUTRITIONAL SUPPLEMENTS - The present disclosure relates to novel nutritional methods and compositions containing essential fatty acids which optimize
79. Treatment of Huntington's Disease With EPA
80. 4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES - This invention relates to novel 4-dimethylaminobutyric acid derivatives of the formula STR00001 wherein A
81. CRYSTALLINE STRUCTURE OF OXIDOSQUALENE SYNTHASE
82. Concentrated Liquid Thyroid Hormone Composition
83. GluR2 receptor modulators - for compositions and methods for modulating the GluR2 receptor
84. NITRIC OXIDE-RELEASING MOLECULES - This invention relates to compositions comprising carbon-based diazeniumdiolates that release nitric oxide
85. GLYCINE TRANSPORT INHIBITORS - compounds of formula or salts or solvates thereof their use in the manufacture of medicaments for treating neurological
86. PRODRUGS OF INHIBITORS OF CATHEPSIN S - compounds of formula which are prodrugs of inhibitors of cathepsin S and as such are useful in the prevention
87. Pan-Antagonists For The Androgen Receptor And Androgen Receptor Mutants Associated With Anti-Androgen Withdrawal
88. 3,5-DIHYDROXY-2,4-CYCLOHEXADIENONES AND THEIR DERIVATIVES, DIETARY COMPOSITIONS AND FORTIFIED FOOD CONTAINING THEM AND THEIR USES
89. Methods for Regulating Gelation of Polysaccharide Solutions and Uses Thereof
90. ACTIVE INGREDIENT CONTAINING STABILISED SOLID MEDICINAL FORMS AND METHOD FOR THE PRODUCTION THEREOF
91. Process for Producing Optically Active Theaspirane
92. Emulsion With Tolerance to Alcohol and Process for Producing the Same
93. CATALYST WITH SUPPORT STRUCTURE - catalyst carrier catalyst and catalyst precursor comprising a refractory metal oxide and support structure comprising
94. POROUS POLYMER STRUCTURES - method of preparing a porous polymer structure comprising the steps of: forming a liquid composition comprising at least one
95. PROCESS FOR PRODUCING FLEXIBLE POLYURETHANE FOAM
96. METHOD FOR MANUFACTURING A FIRE RESISTANT FOAM
97. BLOWING AGENTS FOR POLYMERIC FOAMS - Provided are foam blowing agents comprising one or more chlorofluoroolefins selected from 1 2-dichloro-1
98. Polyurethane foam-forming compositions containing polysilsesquioxane cell opening agents
99. POLYLACTIC ACID FOAM - comprising a resin composition that comprises polylactic acid
100. THERMOPLASTIC ELASTOMER COMPOSITION, FOAM PRODUCT, AND PROCESS FOR PRODUCTION OF THE COMPOSITION OR FOAM PRODUCT
previous page next page
Archives
09-04-08 07-02-09 10-16-08 05-28-09 12-25-08 10-01-09 09-11-08 07-09-09 02-26-09 08-13-0911-20-08 07-30-09 12-18-08 09-10-09 11-27-08 04-16-09 06-11-09 01-08-09 05-14-09 11-06-08
08-27-09 09-24-09 10-15-09 06-18-09 09-17-09 03-26-09 01-15-09 10-30-08 06-25-09 12-04-08
10-08-09 08-06-09 02-19-09 06-04-09 10-23-08 02-12-09 04-23-09 09-25-08 05-21-09 01-29-09
03-05-09 12-11-08 03-19-09 04-30-09 01-01-09 10-22-09 07-23-09 07-16-09 05-07-09 02-05-09
03-12-09 10-02-08 04-09-09 09-03-09 08-20-09 04-02-09 10-09-08 11-13-08 01-22-09 08-28-08
09-18-08 08-21-08